Trending Movers to Watch: PTC Therapeutics, Inc. (NASDAQ:PTCT), Rite Aid Corporation (NYSE:RAD)

On Friday, Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT), added 88.33% and closed at $11.30 in the last trading session. The last trading range of the stock ranges between $9.75 and $11.63. The company’s Market capitalization is $730.35 million with the total Outstanding Shares of 34.32 million. PTC Therapeutics, Inc. (PTCT) recently declared that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the renewal of the conditional marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients five years and older. In connection with the renewal, the marketing authorization will include a specific obligation to conduct an additional long-term post-authorization trial.

“We are happy with this outcome which took into account all available data for Translarna,” said Stuart W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. “This decision reflects the benefit that Translarna is having for patients suffering from nonsense mutation Duchenne muscular dystrophy.”

The CHMP opinion forms the basis for a European Commission decision on the renewal of the marketing authorization. The European Commission generally delivers its decision within three months.

Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $4.03 and reached to max level of $35.40. The EPS of company is strolling at-4.89.

Shares of Rite Aid Corporation (NYSE:RAD), jumped 3.27% and closed at $7.27 in the last trading session. The last trading range of the stock ranges between $7.00 and $7.33. The company’s Market capitalization is $7.90 Billion with the total Outstanding Shares of 1.05 billion. Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy Segment sells prescription drugs; and a range of other merchandises, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services, counting screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides health coaching, shared decision making tools, and health care analytics, counting health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. The Pharmacy Services Segment provides pharmacy benefit administration (PBM) services and a range of pharmacy-related services. It also offers integrated mail-order and specialty pharmacy services; and performs prescription adjudication services for other PBMs.

Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $6.33 and reached to max level of $8.30. The EPS of company is strolling at 0.13.

Leave a Reply

Your email address will not be published. Required fields are marked *